Cara Therapeutics Ownership 2024 | Who Owns Cara Therapeutics Now?
Institutional Ownership
32.29%
Insider Ownership
15.75%
Retail Ownership
51.97%
Institutional Holders
79.00
Cara Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.12% | - | 2,250,334 | -230,924 | -9.31% | 580,586 | Jun 30, 2024 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 3.55% | 0.01% | 1,935,718 | 120,660 | 6.65% | 499,415 | Jun 30, 2024 |
| CHESCAPMANAGER LLC | 3.12% | 0.04% | 1,702,110 | - | - | 439,144 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 2.85% | 0.00% | 1,556,251 | - | - | 401,513 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 1.97% | 0.00% | 1,076,807 | 790,602 | 276.24% | 277,816 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.95% | 0.00% | 1,065,750 | -266,728 | -20.02% | 274,964 | Jun 30, 2024 |
| BLACKROCK INC. | 1.36% | - | 744,707 | -2,676,656 | -78.23% | 192,134 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.07% | 0.00% | 586,755 | -75,079 | -11.34% | 151,383 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.88% | - | 477,683 | -158,547 | -24.92% | 123,242 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.87% | - | 472,686 | -548,913 | -53.73% | 121,984 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.81% | 0.00% | 443,151 | -298,223 | -40.23% | 114,333 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.76% | 0.01% | 414,731 | 414,731 | 100.00% | 107,001 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.71% | - | 389,681 | 338,038 | 654.57% | 100,537 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.68% | - | 369,706 | -21,101 | -5.40% | 95,384,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.49% | 0.00% | 267,303 | -66,928 | -20.02% | 68,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.47% | 0.00% | 254,169 | -23,809 | -8.57% | 65,576 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.41% | - | 223,213 | -105,578 | -32.11% | 57,589 | Jun 30, 2024 |
| STATE STREET CORP | 0.33% | - | 180,800 | -822,154 | -81.97% | 46,646,000 | Jun 30, 2024 |
| FMR LLC | 0.33% | - | 177,523 | 15,388 | 9.49% | 45,801 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.30% | 0.00% | 163,697 | 163,697 | 100.00% | 42,000 | Jun 30, 2024 |
Cara Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 4.12% of the company's total share outstanding, currently valued at $580.59K. The top 10 institutional shareholders own together 21.74% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CHESCAPMANAGER LLC | 3.12% | 0.04% | 1,702,110 | - | - | 439,144 | Jun 30, 2024 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 3.55% | 0.01% | 1,935,718 | 120,660 | 6.65% | 499,415 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.29% | 0.01% | 159,469 | 159,469 | 100.00% | 41,143 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.76% | 0.01% | 414,731 | 414,731 | 100.00% | 107,001 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 2.85% | 0.00% | 1,556,251 | - | - | 401,513 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.14% | 0.00% | 75,987 | 75,987 | 100.00% | 20,000 | Jun 30, 2024 |
| CYPRESS CAPITAL MANAGEMENT LLC (WY) | 0.01% | 0.00% | 5,000 | - | - | 1,290 | Jun 30, 2024 |
| WEALTH EFFECTS LLC | 0.02% | 0.00% | 13,500 | 13,500 | 100.00% | 3,483 | Jun 30, 2024 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.04% | 0.00% | 19,864 | 19,864 | 100.00% | 5,125 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.95% | 0.00% | 1,065,750 | -266,728 | -20.02% | 274,964 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.18% | 0.00% | 96,800 | 96,800 | 100.00% | 24,974 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.10% | 0.00% | 55,000 | 55,000 | 100.00% | 14,190 | Jun 30, 2024 |
| JAG CAPITAL MANAGEMENT, LLC | 0.02% | 0.00% | 11,235 | - | - | 2,899 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.30% | 0.00% | 163,697 | 163,697 | 100.00% | 42,000 | Jun 30, 2024 |
| PINNACLE ASSOCIATES LTD | 0.11% | 0.00% | 57,350 | 57,350 | 100.00% | 14,796 | Jun 30, 2024 |
| PENSERRA CAPITAL MANAGEMENT LLC | 0.12% | 0.00% | 68,078 | 2,540 | 3.88% | 18,000 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 1.97% | 0.00% | 1,076,807 | 790,602 | 276.24% | 277,816 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.49% | 0.00% | 267,303 | -66,928 | -20.02% | 68,000 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.01% | 0.00% | 7,571 | 296 | 4.07% | 1,954 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.02% | 0.00% | 12,866 | 12,866 | 100.00% | 2,703 | Jun 30, 2024 |
The largest Cara Therapeutics shareholder by % of total assets is CHESCAPMANAGER LLC. The company owns 1.70M shares of Cara Therapeutics (CARA), representing 0.04% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BNP PARIBAS ARBITRAGE, SNC | 1.97% | 0.00% | 1,076,807 | 790,602 | 276.24% | 277,816 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.76% | 0.01% | 414,731 | 414,731 | 100.00% | 107,001 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.71% | - | 389,681 | 338,038 | 654.57% | 100,537 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.30% | 0.00% | 163,697 | 163,697 | 100.00% | 42,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.29% | 0.01% | 159,469 | 159,469 | 100.00% | 41,143 | Jun 30, 2024 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 3.55% | 0.01% | 1,935,718 | 120,660 | 6.65% | 499,415 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.18% | 0.00% | 96,800 | 96,800 | 100.00% | 24,974 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.14% | 0.00% | 75,987 | 75,987 | 100.00% | 20,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.12% | - | 66,610 | 66,610 | 100.00% | 17,186 | Jun 30, 2024 |
| PINNACLE ASSOCIATES LTD | 0.11% | 0.00% | 57,350 | 57,350 | 100.00% | 14,796 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.10% | 0.00% | 55,000 | 55,000 | 100.00% | 14,190 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.14% | - | 74,857 | 40,817 | 119.91% | 19,313 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | - | 24,405 | 24,405 | 100.00% | 6,296 | Jun 30, 2024 |
| UBS GROUP AG | 0.13% | - | 73,037 | 21,605 | 42.01% | 18,844 | Jun 30, 2024 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.04% | 0.00% | 19,864 | 19,864 | 100.00% | 5,125 | Jun 30, 2024 |
| FMR LLC | 0.33% | - | 177,523 | 15,388 | 9.49% | 45,801 | Jun 30, 2024 |
| WEALTH EFFECTS LLC | 0.02% | 0.00% | 13,500 | 13,500 | 100.00% | 3,483 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.02% | - | 13,141 | 13,141 | 100.00% | 3,390 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.02% | 0.00% | 12,866 | 12,866 | 100.00% | 2,703 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 22,527 | 11,102 | 97.17% | 5,812 | Jun 30, 2024 |
As of Jun 30 2024, Cara Therapeutics's largest institutional buyer is BNP PARIBAS ARBITRAGE, SNC. The company purchased 790.60K stocks of CARA, valued at $277.82K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 1.36% | - | 744,707 | -2,676,656 | -78.23% | 192,134 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | - | - | - | -1,548,893 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 0.33% | - | 180,800 | -822,154 | -81.97% | 46,646,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.87% | - | 472,686 | -548,913 | -53.73% | 121,984 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -512,213 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -390,602 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.81% | 0.00% | 443,151 | -298,223 | -40.23% | 114,333 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.95% | 0.00% | 1,065,750 | -266,728 | -20.02% | 274,964 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.12% | - | 2,250,334 | -230,924 | -9.31% | 580,586 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -201,871 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.03% | - | 14,353 | -158,978 | -91.72% | 3,703 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.88% | - | 477,683 | -158,547 | -24.92% | 123,242 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -143,494 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -141,150 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -113,930 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.41% | - | 223,213 | -105,578 | -32.11% | 57,589 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -94,238 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -87,320 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.07% | 0.00% | 586,755 | -75,079 | -11.34% | 151,383 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.49% | 0.00% | 267,303 | -66,928 | -20.02% | 68,000 | Jun 30, 2024 |
As of Jun 30 2024, Cara Therapeutics's biggest institutional seller is BLACKROCK INC.. The company sold -2.68M shares of CARA, valued at $192.13K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| Y-INTERCEPT (HONG KONG) LTD | 0.76% | 0.01% | 414,731 | 414,731 | 100.00% | 107,001 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.29% | 0.01% | 159,469 | 159,469 | 100.00% | 41,143 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.18% | 0.00% | 96,800 | 96,800 | 100.00% | 24,974 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.14% | 0.00% | 75,987 | 75,987 | 100.00% | 20,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.12% | - | 66,610 | 66,610 | 100.00% | 17,186 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.10% | 0.00% | 55,000 | 55,000 | 100.00% | 14,190 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | - | 24,405 | 24,405 | 100.00% | 6,296 | Jun 30, 2024 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.04% | 0.00% | 19,864 | 19,864 | 100.00% | 5,125 | Jun 30, 2024 |
| WEALTH EFFECTS LLC | 0.02% | 0.00% | 13,500 | 13,500 | 100.00% | 3,483 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 2,380 | 2,380 | 100.00% | 614 | Jun 30, 2024 |
Cara Therapeutics's largest new institutional shareholder by number of shares is Y-INTERCEPT (HONG KONG) LTD, purchased 414.73K shares, valued at $107.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROSALIND ADVISORS, INC. | - | - | - | -1,548,893 | -100.00% | - | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -512,213 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -390,602 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -201,871 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -143,494 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -141,150 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -113,930 | -100.00% | - | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -94,238 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -87,320 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -45,268 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -36,236 | -100.00% | - | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | - | - | - | -35,791 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -25,403 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -23,050 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -21,214 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -21,176 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -18,545 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -16,942 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -16,507 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -16,384 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -15,992 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -12,308 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -11,861 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -10,980 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -10,451 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -8,656 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -5,311 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -4,661 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -4,335 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -3,311 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,529 | -100.00% | - | Jun 30, 2024 |
| CWM, LLC | - | - | - | -1,343 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -917 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -634 | -100.00% | - | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -176 | -100.00% | - | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | - | - | - | -17 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Cara Therapeutics's largest sold out institutional shareholder by shares sold is ROSALIND ADVISORS, INC., sold -1.55M shares, valued at -, as of undefined.
Cara Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AMERICAN GROWTH FUND INC | 2.37% | 2,265 | - | - | Jul 31, 2023 |
| Federated Hermes MDT Series | 0.32% | 800,390 | 41,434 | 5.46% | Jan 31, 2024 |
| ROYCE VALUE TRUST, INC. | 0.25% | 202,300 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.12% | 383,715 | - | - | Mar 31, 2024 |
| SYNTAX ETF TRUST | 0.10% | 3,297 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.10% | 377,827 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.10% | 478,119 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 33,414 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.06% | 497,110 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 141,200 | - | - | Mar 28, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.06% | 64,940 | - | - | Jan 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.06% | 252,040 | - | - | Feb 29, 2024 |
| ETF Managers Trust | 0.06% | 434,527 | - | - | Dec 31, 2023 |
| FRANKLIN STRATEGIC SERIES | 0.05% | 454,000 | - | - | Jan 31, 2024 |
| Spinnaker ETF Series | 0.05% | 19,346 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.05% | 37,699 | - | - | Dec 31, 2023 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.05% | 26,631 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 239,548 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.02% | 85,121 | - | - | Mar 28, 2024 |
| IndexIQ ETF Trust | 0.02% | 47,169 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.02% | 390 | - | - | Dec 31, 2023 |
| VANGUARD HORIZON FUNDS | 0.01% | 345,530 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 95,825 | 58,437 | 156.30% | Aug 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 8,323 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 77,774 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 17,336 | - | - | Mar 31, 2024 |
| Guardian Variable Products Trust | 0.01% | 165,600 | - | - | Mar 31, 2024 |
| FORUM FUNDS | 0.01% | 20,935 | - | - | Jan 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.01% | 46,822 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.01% | 201,871 | 56,979 | 39.33% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 8,659 | - | - | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 29,125 | - | - | Mar 31, 2020 |
| FIDELITY COVINGTON TRUST | 0.01% | 94,730 | -1,095 | -1.14% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 2,000,066 | -645,753 | -24.41% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,052 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 18,160 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 56,907 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 106,260 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 35,791 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 107,050 | -214,989 | -66.76% | Jan 31, 2024 |
| Amplify ETF Trust | 0.00% | 65,538 | -16,004 | -19.63% | Mar 31, 2024 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.00% | 109,000 | - | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 436,160 | 44,185 | 11.27% | Feb 29, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 396,991 | - | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 15,900 | - | - | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,311 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 17,506 | - | - | Feb 29, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 2,880 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,488 | - | - | Mar 31, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 11,140 | - | - | Dec 31, 2023 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 690 | - | - | Sep 30, 2023 |
| TIMOTHY PLAN | 0.00% | 4,381 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 274,682 | - | - | Jan 31, 2024 |
| SHELTON FUNDS | 0.00% | 1,387 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,986 | -1,539 | -13.35% | Mar 31, 2024 |
| Catholic Responsible Investments Funds | 0.00% | 27,500 | 82 | 0.30% | Jan 31, 2023 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 23,178 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 167,355 | 26,386 | 18.72% | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,942 | - | - | Dec 31, 2023 |
| SunAmerica Specialty Series | 0.00% | 339 | - | - | Apr 30, 2021 |
| AMG Funds I | 0.00% | 1,234 | - | - | Jan 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 5,497 | - | - | Dec 31, 2023 |
| AMG FUNDS III | 0.00% | 2,987 | - | - | Mar 28, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 39,613 | - | - | Mar 28, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,213 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 17,900 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 8,301 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 44,731 | - | - | Mar 28, 2024 |
| Virtus Strategy Trust | 0.00% | 8,001 | - | - | Mar 28, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 4,888 | -212 | -4.16% | Mar 31, 2023 |
| Guggenheim Variable Funds Trust | 0.00% | 1,478 | - | - | Dec 31, 2023 |
| VIRTUS ASSET TRUST | 0.00% | 9,092 | - | - | Mar 28, 2024 |
| HC CAPITAL TRUST | 0.00% | 11,197 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 1,791 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 3,212 | - | - | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 166,824 | -93,291 | -35.87% | Feb 29, 2024 |
| Trust for Advised Portfolios | 0.00% | 5,311 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 679 | - | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,972 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 1,740 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 73,145 | - | - | Jan 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 24,153 | - | - | Jan 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 19,375 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 4,179 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,300 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 22,810 | -8,500 | -27.15% | Mar 28, 2024 |
| JPMORGAN TRUST II | 0.00% | 162,900 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 176,319 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 660 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 8,377 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 2,856 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 6,064 | - | - | Mar 31, 2024 |
| Chartwell Funds | 0.00% | 2,517 | - | - | Jun 30, 2022 |
| Voya INVESTORS TRUST | 0.00% | 6,317 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,751,306 | -107,436 | -5.78% | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 641 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,330 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 427 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 202,891 | 22,144 | 12.25% | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 7,565 | - | - | Jan 31, 2024 |
Cara Therapeutics's largest mutual fund holder by % of total assets is "AMERICAN GROWTH FUND INC", owning 2.27K shares, compromising 2.37% of its total assets.
Cara Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 79 | -21.00% |
| 31 Mar, 24 | 100 | -11.50% |
| 31 Dec, 23 | 113 | -10.32% |
| 30 Sep, 23 | 126 | -10.00% |
| 30 Jun, 23 | 140 | -16.17% |
| 31 Mar, 23 | 167 | -0.60% |
| 31 Dec, 22 | 168 | 3.07% |
| 30 Sep, 22 | 163 | -9.44% |
| 30 Jun, 22 | 180 | -5.26% |
| 31 Mar, 22 | 190 | -1.04% |
| 31 Dec, 21 | 192 | 6.67% |
| 30 Sep, 21 | 180 | -4.26% |
| 30 Jun, 21 | 188 | 1.08% |
| 31 Mar, 21 | 186 | 12.05% |
| 31 Dec, 20 | 166 | -1.19% |
| 30 Sep, 20 | 168 | 7.69% |
| 30 Jun, 20 | 156 | 8.33% |
| 31 Mar, 20 | 144 | -11.66% |
| 31 Dec, 19 | 163 | 7.95% |
| 30 Sep, 19 | 151 | 8.63% |
| 30 Jun, 19 | 139 | -8.55% |
| 31 Mar, 19 | 152 | 5.56% |
| 31 Dec, 18 | 144 | -11.66% |
| 30 Sep, 18 | 163 | 11.64% |
| 30 Jun, 18 | 146 | 14.06% |
| 31 Mar, 18 | 128 | -4.48% |
| 31 Dec, 17 | 134 | 1.52% |
| 30 Sep, 17 | 132 | -16.98% |
| 30 Jun, 17 | 159 | 17.78% |
| 31 Mar, 17 | 135 | 26.17% |
| 31 Dec, 16 | 107 | 25.88% |
| 30 Sep, 16 | 85 | 23.19% |
| 30 Jun, 16 | 69 | -28.13% |
| 31 Mar, 16 | 96 | -2.04% |
| 31 Dec, 15 | 98 | 5.38% |
| 30 Sep, 15 | 93 | 24.00% |
| 30 Jun, 15 | 75 | 27.12% |
| 31 Mar, 15 | 59 | 3.51% |
| 31 Dec, 14 | 57 | 1.79% |
| 30 Sep, 14 | 56 | 12.00% |
| 30 Jun, 14 | 50 | 19.05% |
| 31 Mar, 14 | 42 | - |
As of 30 Jun 24, 79 institutions are holding Cara Therapeutics's shares, representing a decrease of -21.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 17,624,442 | -25.36% |
| 31 Mar, 24 | 23,611,820 | -2.99% |
| 31 Dec, 23 | 24,339,169 | -10.27% |
| 30 Sep, 23 | 27,124,312 | -7.71% |
| 30 Jun, 23 | 29,389,694 | -13.28% |
| 31 Mar, 23 | 33,889,767 | -0.18% |
| 31 Dec, 22 | 33,952,529 | -1.79% |
| 30 Sep, 22 | 34,571,236 | -0.70% |
| 30 Jun, 22 | 34,815,085 | 9.70% |
| 31 Mar, 22 | 31,737,451 | 4.72% |
| 31 Dec, 21 | 30,306,106 | 2.39% |
| 30 Sep, 21 | 29,598,595 | -4.97% |
| 30 Jun, 21 | 31,145,278 | -3.90% |
| 31 Mar, 21 | 32,408,530 | -0.78% |
| 31 Dec, 20 | 32,663,896 | -2.17% |
| 30 Sep, 20 | 33,389,437 | 2.09% |
| 30 Jun, 20 | 32,707,340 | 1.57% |
| 31 Mar, 20 | 32,202,243 | 2.72% |
| 31 Dec, 19 | 31,349,906 | 2.74% |
| 30 Sep, 19 | 30,514,144 | 17.32% |
| 30 Jun, 19 | 26,008,379 | 16.64% |
| 31 Mar, 19 | 22,298,897 | -7.96% |
| 31 Dec, 18 | 24,226,814 | 3.13% |
| 30 Sep, 18 | 23,490,778 | 22.84% |
| 30 Jun, 18 | 19,122,895 | 6.72% |
| 31 Mar, 18 | 17,918,931 | 3.85% |
| 31 Dec, 17 | 17,253,868 | -9.66% |
| 30 Sep, 17 | 19,099,662 | -4.13% |
| 30 Jun, 17 | 19,922,317 | 17.04% |
| 31 Mar, 17 | 17,021,536 | 23.07% |
| 31 Dec, 16 | 13,830,269 | 19.12% |
| 30 Sep, 16 | 11,610,030 | -12.88% |
| 30 Jun, 16 | 13,326,047 | -18.48% |
| 31 Mar, 16 | 16,346,198 | -19.14% |
| 31 Dec, 15 | 20,214,219 | 8.70% |
| 30 Sep, 15 | 18,595,711 | 54.12% |
| 30 Jun, 15 | 12,065,654 | 8.22% |
| 31 Mar, 15 | 11,149,420 | 6.88% |
| 31 Dec, 14 | 10,431,785 | 6.83% |
| 30 Sep, 14 | 9,764,866 | 10.98% |
| 30 Jun, 14 | 8,798,847 | 2.06% |
| 31 Mar, 14 | 8,621,122 | - |
Cara Therapeutics (CARA) has 17.62M shares outstanding as of 30 Jun 24, down -25.36% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 32.29% | 1.70% |
| 31 Mar, 24 | 43.61% | 2.17% |
| 31 Dec, 23 | 44.88% | 1.78% |
| 30 Sep, 23 | 50.23% | 1.69% |
| 30 Jun, 23 | 54.55% | 1.38% |
| 31 Mar, 23 | 62.91% | 1.58% |
| 31 Dec, 22 | 63.15% | 1.53% |
| 30 Sep, 22 | 64.35% | 1.53% |
| 30 Jun, 22 | 64.94% | 1.85% |
| 31 Mar, 22 | 59.31% | 1.80% |
| 31 Dec, 21 | 57.44% | 1.65% |
| 30 Sep, 21 | 59.06% | 1.53% |
| 30 Jun, 21 | 62.22% | 1.48% |
| 31 Mar, 21 | 64.92% | 1.37% |
| 31 Dec, 20 | 68.89% | 1.36% |
| 30 Sep, 20 | 71.22% | 1.46% |
| 30 Jun, 20 | 69.89% | 1.47% |
| 31 Mar, 20 | 68.92% | 1.53% |
| 31 Dec, 19 | 67.14% | 1.43% |
| 30 Sep, 19 | 68.54% | 1.61% |
| 30 Jun, 19 | 65.32% | 2.06% |
| 31 Mar, 19 | 56.38% | 1.49% |
| 31 Dec, 18 | 61.42% | 1.61% |
| 30 Sep, 18 | 61.76% | 1.87% |
| 30 Jun, 18 | 57.40% | 1.91% |
| 31 Mar, 18 | 54.83% | 1.96% |
| 31 Dec, 17 | 52.87% | 1.54% |
| 30 Sep, 17 | 58.60% | 1.53% |
| 30 Jun, 17 | 61.79% | 1.59% |
| 31 Mar, 17 | 62.35% | 2.43% |
| 31 Dec, 16 | 50.70% | 2.80% |
| 30 Sep, 16 | 42.55% | 1.78% |
| 30 Jun, 16 | 48.84% | 1.36% |
| 31 Mar, 16 | 59.96% | 1.09% |
| 31 Dec, 15 | 74.21% | 1.40% |
| 30 Sep, 15 | 72.80% | 2.61% |
| 30 Jun, 15 | 52.85% | 2.21% |
| 31 Mar, 15 | 48.88% | 2.33% |
| 31 Dec, 14 | 45.77% | 2.48% |
| 30 Sep, 14 | 42.99% | 2.84% |
| 30 Jun, 14 | 38.92% | 1.28% |
| 31 Mar, 14 | 55.07% | - |
As of 30 Jun 24, Cara Therapeutics is held by 32.29% institutional shareholders, representing a 1.70% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 30 | -16.67% |
| 31 Mar, 24 | 36 | -21.74% |
| 31 Dec, 23 | 46 | -11.54% |
| 30 Sep, 23 | 52 | -24.64% |
| 30 Jun, 23 | 69 | 4.55% |
| 31 Mar, 23 | 66 | -17.50% |
| 31 Dec, 22 | 80 | -2.44% |
| 30 Sep, 22 | 82 | 7.89% |
| 30 Jun, 22 | 76 | 1.33% |
| 31 Mar, 22 | 75 | -16.67% |
| 31 Dec, 21 | 90 | 18.42% |
| 30 Sep, 21 | 76 | -20.00% |
| 30 Jun, 21 | 95 | 18.75% |
| 31 Mar, 21 | 80 | 17.65% |
| 31 Dec, 20 | 68 | 4.62% |
| 30 Sep, 20 | 65 | -18.75% |
| 30 Jun, 20 | 80 | 42.86% |
| 31 Mar, 20 | 56 | -28.21% |
| 31 Dec, 19 | 78 | -6.02% |
| 30 Sep, 19 | 83 | 31.75% |
| 30 Jun, 19 | 63 | - |
| 31 Mar, 19 | 63 | -1.56% |
| 31 Dec, 18 | 64 | -25.58% |
| 30 Sep, 18 | 86 | 19.44% |
| 30 Jun, 18 | 72 | 63.64% |
| 31 Mar, 18 | 44 | -20.00% |
| 31 Dec, 17 | 55 | 7.84% |
| 30 Sep, 17 | 51 | -40.00% |
| 30 Jun, 17 | 85 | 18.06% |
| 31 Mar, 17 | 72 | 12.50% |
| 31 Dec, 16 | 64 | 48.84% |
| 30 Sep, 16 | 43 | 19.44% |
| 30 Jun, 16 | 36 | -25.00% |
| 31 Mar, 16 | 48 | -7.69% |
| 31 Dec, 15 | 52 | -22.39% |
| 30 Sep, 15 | 67 | 24.07% |
| 30 Jun, 15 | 54 | 58.82% |
| 31 Mar, 15 | 34 | 13.33% |
| 31 Dec, 14 | 30 | -3.23% |
| 30 Sep, 14 | 31 | -3.13% |
| 30 Jun, 14 | 32 | -23.81% |
| 31 Mar, 14 | 42 | - |
30 institutional shareholders have increased their position in CARA stock as of 30 Jun 24 compared to 36 in the previous quarter (a -16.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 22 | -33.33% |
| 31 Mar, 24 | 33 | -2.94% |
| 31 Dec, 23 | 34 | -19.05% |
| 30 Sep, 23 | 42 | 7.69% |
| 30 Jun, 23 | 39 | -36.07% |
| 31 Mar, 23 | 61 | 38.64% |
| 31 Dec, 22 | 44 | 2.33% |
| 30 Sep, 22 | 43 | -27.12% |
| 30 Jun, 22 | 59 | -19.18% |
| 31 Mar, 22 | 73 | 35.19% |
| 31 Dec, 21 | 54 | -1.82% |
| 30 Sep, 21 | 55 | 5.77% |
| 30 Jun, 21 | 52 | 4.00% |
| 31 Mar, 21 | 50 | -1.96% |
| 31 Dec, 20 | 51 | 6.25% |
| 30 Sep, 20 | 48 | 71.43% |
| 30 Jun, 20 | 28 | -34.88% |
| 31 Mar, 20 | 43 | 4.88% |
| 31 Dec, 19 | 41 | 13.89% |
| 30 Sep, 19 | 36 | 24.14% |
| 30 Jun, 19 | 29 | -25.64% |
| 31 Mar, 19 | 39 | -4.88% |
| 31 Dec, 18 | 41 | 41.38% |
| 30 Sep, 18 | 29 | -6.45% |
| 30 Jun, 18 | 31 | -13.89% |
| 31 Mar, 18 | 36 | -7.69% |
| 31 Dec, 17 | 39 | -9.30% |
| 30 Sep, 17 | 43 | 16.22% |
| 30 Jun, 17 | 37 | 19.35% |
| 31 Mar, 17 | 31 | 24.00% |
| 31 Dec, 16 | 25 | 38.89% |
| 30 Sep, 16 | 18 | -10.00% |
| 30 Jun, 16 | 20 | -31.03% |
| 31 Mar, 16 | 29 | -6.45% |
| 31 Dec, 15 | 31 | 72.22% |
| 30 Sep, 15 | 18 | 50.00% |
| 30 Jun, 15 | 12 | 9.09% |
| 31 Mar, 15 | 11 | -38.89% |
| 31 Dec, 14 | 18 | 5.88% |
| 30 Sep, 14 | 17 | 41.67% |
| 30 Jun, 14 | 12 | - |
| 31 Mar, 14 | - | - |
22 institutional shareholders have reduced their position in CARA stock as of 30 Jun 24 compared to 33 in the previous quarter (a -33.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 79 | -21.00% | 17,624,442 | -25.36% | 32.29% | 1.70% | 30 | -16.67% | 22 | -33.33% |
| 31 Mar, 24 | 100 | -11.50% | 23,611,820 | -2.99% | 43.61% | 2.17% | 36 | -21.74% | 33 | -2.94% |
| 31 Dec, 23 | 113 | -10.32% | 24,339,169 | -10.27% | 44.88% | 1.78% | 46 | -11.54% | 34 | -19.05% |
| 30 Sep, 23 | 126 | -10.00% | 27,124,312 | -7.71% | 50.23% | 1.69% | 52 | -24.64% | 42 | 7.69% |
| 30 Jun, 23 | 140 | -16.17% | 29,389,694 | -13.28% | 54.55% | 1.38% | 69 | 4.55% | 39 | -36.07% |
| 31 Mar, 23 | 167 | -0.60% | 33,889,767 | -0.18% | 62.91% | 1.58% | 66 | -17.50% | 61 | 38.64% |
| 31 Dec, 22 | 168 | 3.07% | 33,952,529 | -1.79% | 63.15% | 1.53% | 80 | -2.44% | 44 | 2.33% |
| 30 Sep, 22 | 163 | -9.44% | 34,571,236 | -0.70% | 64.35% | 1.53% | 82 | 7.89% | 43 | -27.12% |
| 30 Jun, 22 | 180 | -5.26% | 34,815,085 | 9.70% | 64.94% | 1.85% | 76 | 1.33% | 59 | -19.18% |
| 31 Mar, 22 | 190 | -1.04% | 31,737,451 | 4.72% | 59.31% | 1.80% | 75 | -16.67% | 73 | 35.19% |
| 31 Dec, 21 | 192 | 6.67% | 30,306,106 | 2.39% | 57.44% | 1.65% | 90 | 18.42% | 54 | -1.82% |
| 30 Sep, 21 | 180 | -4.26% | 29,598,595 | -4.97% | 59.06% | 1.53% | 76 | -20.00% | 55 | 5.77% |
| 30 Jun, 21 | 188 | 1.08% | 31,145,278 | -3.90% | 62.22% | 1.48% | 95 | 18.75% | 52 | 4.00% |
| 31 Mar, 21 | 186 | 12.05% | 32,408,530 | -0.78% | 64.92% | 1.37% | 80 | 17.65% | 50 | -1.96% |
| 31 Dec, 20 | 166 | -1.19% | 32,663,896 | -2.17% | 68.89% | 1.36% | 68 | 4.62% | 51 | 6.25% |
| 30 Sep, 20 | 168 | 7.69% | 33,389,437 | 2.09% | 71.22% | 1.46% | 65 | -18.75% | 48 | 71.43% |
| 30 Jun, 20 | 156 | 8.33% | 32,707,340 | 1.57% | 69.89% | 1.47% | 80 | 42.86% | 28 | -34.88% |
| 31 Mar, 20 | 144 | -11.66% | 32,202,243 | 2.72% | 68.92% | 1.53% | 56 | -28.21% | 43 | 4.88% |
| 31 Dec, 19 | 163 | 7.95% | 31,349,906 | 2.74% | 67.14% | 1.43% | 78 | -6.02% | 41 | 13.89% |
| 30 Sep, 19 | 151 | 8.63% | 30,514,144 | 17.32% | 68.54% | 1.61% | 83 | 31.75% | 36 | 24.14% |
| 30 Jun, 19 | 139 | -8.55% | 26,008,379 | 16.64% | 65.32% | 2.06% | 63 | - | 29 | -25.64% |
| 31 Mar, 19 | 152 | 5.56% | 22,298,897 | -7.96% | 56.38% | 1.49% | 63 | -1.56% | 39 | -4.88% |
| 31 Dec, 18 | 144 | -11.66% | 24,226,814 | 3.13% | 61.42% | 1.61% | 64 | -25.58% | 41 | 41.38% |
| 30 Sep, 18 | 163 | 11.64% | 23,490,778 | 22.84% | 61.76% | 1.87% | 86 | 19.44% | 29 | -6.45% |
| 30 Jun, 18 | 146 | 14.06% | 19,122,895 | 6.72% | 57.40% | 1.91% | 72 | 63.64% | 31 | -13.89% |
| 31 Mar, 18 | 128 | -4.48% | 17,918,931 | 3.85% | 54.83% | 1.96% | 44 | -20.00% | 36 | -7.69% |
| 31 Dec, 17 | 134 | 1.52% | 17,253,868 | -9.66% | 52.87% | 1.54% | 55 | 7.84% | 39 | -9.30% |
| 30 Sep, 17 | 132 | -16.98% | 19,099,662 | -4.13% | 58.60% | 1.53% | 51 | -40.00% | 43 | 16.22% |
| 30 Jun, 17 | 159 | 17.78% | 19,922,317 | 17.04% | 61.79% | 1.59% | 85 | 18.06% | 37 | 19.35% |
| 31 Mar, 17 | 135 | 26.17% | 17,021,536 | 23.07% | 62.35% | 2.43% | 72 | 12.50% | 31 | 24.00% |
| 31 Dec, 16 | 107 | 25.88% | 13,830,269 | 19.12% | 50.70% | 2.80% | 64 | 48.84% | 25 | 38.89% |
| 30 Sep, 16 | 85 | 23.19% | 11,610,030 | -12.88% | 42.55% | 1.78% | 43 | 19.44% | 18 | -10.00% |
| 30 Jun, 16 | 69 | -28.13% | 13,326,047 | -18.48% | 48.84% | 1.36% | 36 | -25.00% | 20 | -31.03% |
| 31 Mar, 16 | 96 | -2.04% | 16,346,198 | -19.14% | 59.96% | 1.09% | 48 | -7.69% | 29 | -6.45% |
| 31 Dec, 15 | 98 | 5.38% | 20,214,219 | 8.70% | 74.21% | 1.40% | 52 | -22.39% | 31 | 72.22% |
| 30 Sep, 15 | 93 | 24.00% | 18,595,711 | 54.12% | 72.80% | 2.61% | 67 | 24.07% | 18 | 50.00% |
| 30 Jun, 15 | 75 | 27.12% | 12,065,654 | 8.22% | 52.85% | 2.21% | 54 | 58.82% | 12 | 9.09% |
| 31 Mar, 15 | 59 | 3.51% | 11,149,420 | 6.88% | 48.88% | 2.33% | 34 | 13.33% | 11 | -38.89% |
| 31 Dec, 14 | 57 | 1.79% | 10,431,785 | 6.83% | 45.77% | 2.48% | 30 | -3.23% | 18 | 5.88% |
| 30 Sep, 14 | 56 | 12.00% | 9,764,866 | 10.98% | 42.99% | 2.84% | 31 | -3.13% | 17 | 41.67% |
| 30 Jun, 14 | 50 | 19.05% | 8,798,847 | 2.06% | 38.92% | 1.28% | 32 | -23.81% | 12 | - |
| 31 Mar, 14 | 42 | - | 8,621,122 | - | 55.07% | - | 42 | - | - | - |
Cara Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cara Therapeutics's stock was made by Posner Christopher on Aug 02 2024, selling 4,149 shares at $0.35 per share (valued at $1.45K).
Cara Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | 10 | 3 | 333.33% |
| Q1 2024 | 5 | 5 | 100.00% |
| Q4 2023 | - | 1 | - |
| Q3 2023 | 1 | 1 | 100.00% |
| Q2 2023 | 10 | 7 | 142.86% |
| Q1 2023 | 6 | 10 | 60.00% |
| Q4 2022 | - | 5 | - |
| Q3 2022 | - | 3 | - |
| Q2 2022 | 11 | 12 | 91.67% |
| Q1 2022 | 12 | 5 | 240.00% |
| Q4 2021 | 7 | 3 | 233.33% |
| Q3 2021 | 5 | 6 | 83.33% |
| Q2 2021 | 10 | 4 | 250.00% |
| Q1 2021 | 16 | 11 | 145.45% |
| Q4 2020 | 6 | 15 | 40.00% |
| Q3 2020 | - | 3 | - |
| Q2 2020 | 16 | 16 | 100.00% |
| Q1 2020 | 12 | 7 | 171.43% |
| Q4 2019 | 6 | 23 | 26.09% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Cara Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 7 | - |
| Q1 2023 | - | 10 | - |
| Q4 2022 | - | 5 | - |
| Q3 2022 | - | 3 | - |
| Q2 2022 | - | 4 | - |
| Q1 2022 | - | 5 | - |
| Q4 2021 | - | 3 | - |
| Q3 2021 | - | 6 | - |
| Q2 2021 | - | 4 | - |
| Q1 2021 | - | 11 | - |
| Q4 2020 | - | 15 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | 13 | - |
| Q1 2020 | - | 4 | - |
| Q4 2019 | - | 13 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Cara Therapeutics's stocks.
CARA Ownership FAQ
Who Owns Cara Therapeutics?
Cara Therapeutics is owned by institutional shareholders (32.29%), insiders (15.75%), and public (51.97%). The largest institutional shareholder of Cara Therapeutics is VANGUARD GROUP INC (4.12% of total shares) and the top mutual fund owner is AMERICAN GROWTH FUND INC (2.37% of total shares).
Who are the major institutional shareholders of Cara Therapeutics?
Cara Therapeutics's major institutional shareholders are VANGUARD GROUP INC, DISCIPLINED GROWTH INVESTORS INC /MN, CHESCAPMANAGER LLC, FARALLON CAPITAL MANAGEMENT LLC, and BNP PARIBAS ARBITRAGE, SNC. The top five shareholders own together 15.61% of the company's share outstanding.
How many Cara Therapeutics shareholders are there?
As of Jun 2024, there are 79 institutional shareholders of Cara Therapeutics.
What percentage of Cara Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 2.25M shares of Cara Therapeutics, representing 4.12% of the company's total shares outstanding, valued at $580.59K (as of Jun 2024).
What percentage of Cara Therapeutics is owned by DISCIPLINED GROWTH INVESTORS INC /MN?
As of Jun 2024, DISCIPLINED GROWTH INVESTORS INC /MN holds 1.94M shares of Cara Therapeutics (CARA), compromising 3.55% of the company, valued at $499.42K.
What percentage of Cara Therapeutics is owned by CHESCAPMANAGER LLC?
CHESCAPMANAGER LLC is the third largest holder of Cara Therapeutics. The company owns 1.7M of the company's shares outstanding (worth $439.14K).